About

DoseMe reshapes the way medicine is dosed, using the world’s first real-time precision dosing software platform – DoseMeRx – to predict the optimal dose of therapeutic drugs at the point of care. This unique software solution determines precise, patient-specific doses for a range of therapeutic areas, including infectious diseases, transplant, coagulation management, paediatrics and oncology.

Company details

Company DoseMe

Service Biotechnology

Websitehttps://doseme-rx.com

DoseMe is the first company in the world to offer precision dosing software specifically developed for clinical use at the point of care. The DoseMeRx platform significantly improves dosing accuracy and patient outcomes by providing real-time, dose-related decision support to enable precision medicine using readily available patient data. DoseMe Crunch is built on the same algorithms that underpin DoseMeRx. DoseMe Crunch can analyse retrospective and previously under-utilised sources of patient data to empower health services to understand and optimise medication use, benchmark clinical dosing practices and monitor medication management performance.

Our offering

DoseMe reshapes the way medicine is dosed, using the world’s first real-time precision dosing software platform – DoseMeRx – to predict the optimal dose of therapeutic drugs at the point of care. This unique software solution determines precise, patient-specific doses for a range of therapeutic areas, including infectious diseases, transplant, coagulation management, paediatrics and oncology. As a cloud-based solution, it offers simple set-up, and users can be live within minutes. Integrated into electronic health record (EHR) systems, including Cerner and Epic, using SMART and FHIR technologies, DoseMeRx delivers simple and easy-to-use precision dosing software never previously available in the EHR.

Today, the approach is to incorporate DoseMeRx into standard clinical practice across acute-care hospitals and out-patient infusion settings. With the tidal wave of bioequivalents, monoclonal antibodies and newer speciality drugs, DoseMe has a major role in shaping precision dosing to help clinical practice move towards a more patient-centred healthcare system, which aligns with new value-based payment models that expect providers to deliver health care that improves patient outcomes and lowers the total costs of care.

Used in over 100 hospitals across the USA, Europe and the Asia-Pacific, DoseMe’s platform has grown 500% in well under 12 months. The fundamental benefits of the DoseMeRx platform mean it has the potential to be in every hospital across the USA – as precision dosing should be for every patient, every dose, and every time.